Rothwell, P.M.

patient aspirin ischemia origin trial placebo study atrial fibrillation randomized fibrillation atrial stroke history swets subs service prevention model patient data hypertension uk tia trial patients randomized spirit treatment afasak group anticoagulation source ischemic attack warfarin ischemic result antithrombotic spaf i aspirin-treated patients anticoagulant characteristic 283 mg /d nonrheumatic atrial fibrillation association stroke prevention intracerebral hemorrhage baseline characteristics diabetes blood smoking service pataf pressure analyses aspirin-treated anticoagulant therapy study center diastolic blood pressures afasak i baseline 2 models attack spirit trial downloaded study group ischemia trial hemorrhage bivariate analyses ischemic stroke february aspirin dose intracerebral aspirin 300 mg crude hr center utrecht double-blind utrecht incidence figure netherland crude health research neurology difference therapy